Neuron23
CA - South SF
Biotechnology1 H-1B visas (FY2023)Focus: AI-drug discovery
Neuron23 is a life sciences company focused on AI-drug discovery.
Neurology
Funding Stage
SERIES C +
Open Jobs
0
Pipeline & Clinical Trials
A Non-interventional Study for the Collection of Biospecimens From Patients With Parkinson's Disease
Parkinson DiseaseClinical Trials (1)
NCT04893083A Non-interventional Study for the Collection of Biospecimens From Patients With Parkinson's Disease
N/ANEU-111
HealthyClinical Trials (1)
NCT06500442A Study to Assess NEU-111 in Healthy Participants
Phase 1NEU-411
HealthyClinical Trials (1)
NCT05755191A Study to Assess NEU-411 in Healthy Participants
Phase 1NEU-723
HealthyClinical Trials (1)
NCT05633745A Study to Assess NEU-723 in Healthy Participants
Phase 1NEU-627
HealthyClinical Trials (1)
NCT06900751A Study to Assess NEU-627 in Healthy Participants
Phase 1NEU-411
Parkinson DiseaseClinical Trials (1)
NCT06680830A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
Phase 2Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Portfolio: 6 clinical trials
H-1B (2023): 1 approval
Hiring Trend
Stable
0
Open Roles
+0
Added
-0
Filled/Removed
Based on last 4 crawl cycles
Visa Sponsorship
Sponsors Work Visas
H-1B Petitions (FY2023)
1
Approved
0
Denied
100%
Rate
Source: USCIS H-1B Employer Data Hub